4-(2-CYCLOPROPYLETHYNYL)-4-(1,1-DIFLUOROETHYL)-6-FLUORO-7-((3-(METHOXYMETHYL)PYRAZOL-1-YL)METHYL)-1,3-DIHYDROQUINAZOLIN-2-ONE, (4S)-
UNII 5PS29CJ8CC
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(2-cyclopropylethynyl)-4-(1,1-difluoroethyl)-6-fluoro-7-((3-(methoxymethyl)pyrazol-1-yl)methyl)-1,3-dihydroquinazolin-2-one, (4s)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5PS29CJ8CC.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3069129-92-3 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H21F3N4O2 PTYQJNINJPHBGR-NRFANRHFSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(2-cyclopropylethynyl)-4-(1,1-difluoroethyl)-6-fluoro-7-((3-(methoxymethyl)pyrazol-1-yl)methyl)-1,3-dihydroquinazolin-2-one, (4s)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.